Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 April 2022
Seminar on Open Science

Publishing academic content behind a paywall not only limits access to scholarly work, but also prevents research output from being visible and making maximum impact. Researchers are paying to publish their research output, and libraries are paying to access it in what is known as double-dipping by publishers, leading to what we term ‘serial crisis’. Research institutions pay twice and still do not see their research widely available to be read.

By signing the Berlin Declaration on Open Access in 2012, the University of the Free State (UFS) committed itself to supporting open access to its research outputs. National initiatives by research institutions and the government make research outputs freely available via national site licensing. The UFS supports this initiative via the South African National Library and Information Consortium (SANLiC) as an interim transformative agreement with publishers, allowing research outputs to be open access, without the additional publication charges.

What do we do about publishers who are unwilling to transform? Do we still pay their massive subscription and publication fees? What do we need to do to ensure that all UFS research outputs are accessible to all?

Topic: Should the UFS continue to subscribe to academic journals that are behind a paywall?
Thursday 12 May 2022
12:00-13:30

Microsoft Teams
RSVP: Elma Viljoen, viljoene@ufs.ac.za (link will be provided)

Join the following top experts for what promises to be an insightful discussion:

  • Colleen Campbell
    Coordinator: Open Access 2020 Initiative
    Max Planck Digital Library, Munich, Germany
  • Ellen Tise
    Senior Director: Library and Information Services, Stellenbosch University

  • Glenn Truran
    Director: South African National Library and Information Consortium (SANLiC)

The welcoming and introduction to the webinar will be conducted by Prof Corli Witthuhn, Vice-Rector: Research.  

Bios of speakers

Colleen Campbell leads external engagement in the open access transition at the Max Planck Digital Library (MPDL) in Munich, Germany. There, she coordinates the Open Access 2020 Initiative, a global alliance of research organisations and their libraries that are driving the transition of today’s scholarly journals to open-access publishing models, and the ESAC Initiative, an international community of practice dedicated to optimising open-access workflows and processes. She is a member of the LIBER Open Access Working Group, serves on the Managing Board of EIFL, a not-for-profit organisation that works with libraries to enable access to knowledge in developing and transition economy countries in Africa, Asia-Pacific, Europe, and Latin America, and contributes to the advisory groups of a number of other scholarly communication initiatives.

Ellen Tise has been the Senior Director of Library and Information Services at Stellenbosch University (SU) since January 2006. She previously held the positions of University Librarian at the University of the Western Cape (UWC) and Deputy University Librarian at the University of the Witwatersrand. She holds a BBibl Honours degree from the UWC and an MPhil in Science and Technology Studies from SU. Among other notable leadership roles, Ms Tise served as the first President of the Library and Information Association of South Africa (LIASA) from 1998 to 2002, and President of the International Federation of Library Associations and Institutions, known as IFLA, for the years 2009 through 2011. She also served as Chair of the Board of the National Library of South Africa (2012-2015), and on the OCLC Board of Trustees (2014-2018). She has just started a second two-year term as Chair of the Freedom of Access to Information and Freedom of Expression Advisory Committee of IFLA. She is the recipient of several awards for distinguished leadership and outstanding contributions to librarianship, including honorary membership of LIASA and an honorary IFLA fellowship. She has published various articles in professional journals and is a regular speaker at national and international conferences, seminars, symposia, etc.

Glenn Truran has been the Director of the South African National Library and Information Consortium (SANLiC) since 2014 and works from home in Cape Town. After graduating from the University of the Witwatersrand (Wits) with a BA and HDipEd (PG), he worked briefly as an educator in South Africa and England. Subsequently, he completed a diploma in Public Policy and Development Administration at Wits and received his MBA from the University of Cape Town in 2003. Before joining SANLiC, he worked in several educational and poverty alleviation non-profit organisations in Gauteng and Cape Town. He has been actively involved in SANLiC’s Open Access Transformational Agreements task team.

Charlie Molepo has been the Deputy Director at the UFS Sasol Library responsible for Research and Scholarly Communications since 2015. He represents the non-academic staff on the University Council and serves on its Finance and Human Resources Committees. Before joining the UFS, he worked at Vista University, the University of Natal, the University of Johannesburg, the University of KwaZulu-Natal Libraries, and Dawson Books UK (Betrams) as the International Account Director for Africa. He serves as President-Elect (2022-2023) in the Library and Information Association of South Africa (LIASA).

News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept